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Abstract: The MeOH/CH2Cl2 (1:1) extracts of the roots and leaves of Beilschmiedia louisii and B. obscura
showed potent antitrypanosomal activity during preliminary screening on Trypanosoma brucei brucei.
Phytochemical investigation of these extracts led to the isolation of a mixture of two new endiandric
acid derivatives beilschmiedol B (1) and beilschmiedol C (2), and one new phenylalkene obscurene A
(3) together with twelve known compounds (4–15). In addition, four new derivatives (11a–11d) were
synthesized from compound 11. Their structures were elucidated based on their NMR and MS data.
Compounds 5, 6, and 7 were isolated for the first time from the Beilschmiedia genus. Additionally,
the NMR data of compound 4 are given here for the first time. The isolates were evaluated for
their antitrypanosomal and antimalarial activities against Tb brucei and the Plasmodium falciparum
chloroquine-resistant strain Pf3D7 in vitro, respectively. From the tested compounds, the mixture of
new compounds 1 and 2 exhibited the most potent antitrypanosomal activity in vitro with IC50 value
of 4.91 µM.
Keywords: Lauraceae; Beilschmiedia obscura; Beilschmiedia louisii; endiandric acid; antitrypanosomal activity
1. Introduction
The genus Beilschmiedia is one of the most widespread genera of the Lauraceae family. It is
commonly distributed in tropical Asia and Africa and comprises of about 250 species. Forty-one of
these species can be found in Cameroon, principally, in the South Western, Center; Eastern, Littoral,
and Western regions [1,2]. Plants of the Beilschmiedia genus are largely used in traditional medicine in
developing countries for the treatment of many ailments. The bark and leaves of some Beilschmiedia
species have been reported to be used in traditional medicine for the treatment of uterine tumors,
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rubella, female genital infections, rheumatism, colon and digestive disorders, malaria, and a headache,
as well as bacterial or fungal infections [3]. In Cameroon, the decoction of the bark of B. obscura is
used in the center region for the treatment of microbial and parasitic infections [4]. The fruits of
B. louisii are used as spice [5,6]. Previous phytochemical studies of plants of Beileschmiedia genus
revealed the presence of various classes of secondary metabolites including alkaloids, arylpropanoids,
benzopyrans, endiandric acids, and flavonoids [7]. Some of these phytoconstituents exhibited
antibacterial, anticancer, antifungal, anti-inflammatory, antileishmanial, antiplasmodial, and cytotoxic
activities as well as the α-glucosidase inhibitory activity during bioassay investigations [3]. To the best
of our knowledge, no phytochemical and pharmacological studies have been reported on B. louissi.
However, previous investigation of B. obscura reported the presence of one alkaloid, obscurine, and
terpenoids [8]. Despite this phytochemical study, no attempt has been made so far to evaluate its
pharmacological properties. In a continuing search for antimalarial and antitrypanosomal active
compounds from Cameroonian medicinal plants, we have investigated the MeOH/CH2Cl2 (1:1) extracts
of the stem bark of B. obscura and the roots of B. louisii, which showed antitrypanosomal activity during
preliminary screening. Therefore, the purpose of the present study was to assess the antitrypanosomal
and antiplasmodial activities of the extracts as well as those of the isolated compounds from these
extracts. We report herein the isolation and structure elucidation of fifteen compounds from the roots
of B. louisii and the stem bark of B. obscura as well as the structure modification of compound 11,
their antitrypanosomal, and antiplasmodial activities.
2. Results and Discussion
2.1. Structure Elucidation
The neutral fraction of the MeOH/CH2Cl2 (1:1) extract of stem bark of B. obscura was subjected
to column chromatography (CC) over silica gel to afford beilschmiedol B (1), beilschmiedol C (2),
and obscurene A (3). In addition, four known compounds including pentacosan-1-ene (4) [9,10],
15-phenylpentadecanoic acid (5) [11], (3S,4R,5S)-4-hydroxy-5-methyl-3-(11′-phenyl-1′-n-undecyl)-butanolide
(6), and (3S,4R,5S)-4-hydroxy-5-methyl-3-(13′-phenyl-1′-n-tridecyl)-butanolide (7) [12] were isolated.
The neutral fraction of the MeOH/CH2Cl2 (1:1) extract of roots of B. louisii was subjected to CC
over silica gel to afford eight known compounds including beilschmiedic acid A (8), beilschmiedic
acid C (9), beilschmiedic acid D (10), beilschmiedic acid E (11) [13,14], methylenedioxyendiandric
acid A (12) [15], β-sitosterol (13) [16], epicatechin (14) [17], and β-sitosterol-3-O-β-D-glucopyranoside
(15) [18]. Furthermore, four new derivatives (11a, 11b, 11c, and 11d) were prepared from compound 11.
The structures of isolates and synthetic derivatives were determined using their spectroscopic data.
The reduction of beilschmiedic acid E (11) [13] using lithium aluminum hydride (LiAlH4) [19]
led to compound 11a (Scheme 1) as an off-yellow oil. Its 13C–NMR spectrum (Table 1; Figure S1)
showed 22 carbon signals, which were sorted by distortionless enhancement by polarization transfer
(DEPT; Figure S3) and heteronuclear single quantum correlation (HSQC; Figure S5) experiments into
twelve methine carbon resonances (including four olefinic carbons at δC 127.9 (C-5), 128.8 (C-9), 131.4
(C-8), and 133.9 (C-4)), nine methylene carbon signals (including one oxymethylene at δC 67.3 (C-1”)),
and one methyl carbon signal at δC 14.3 (C-8′). In addition, the 13C–NMR spectrum of 11a exhibited
characteristic carbon signals for a tetracyclic alcohol with an endiandric acid skeleton containing the
∆4,5 and ∆8,9 carbon–carbon double bond equivalents [4,13–15,20,21]. The 1H–NMR spectrum (Table 1;
Figure S2) showed signals of four olefinic protons at δH 6.10 (1H, dt, J = 10.0, 2.4 Hz, H-4), 5.50 (1H,
dt, J = 10.0, 2.8 Hz, H-5), 5.39 (1H, brdd, J = 10.0, 0.8 Hz, H-8), and 5.56 (1H, dt, J = 10.0, 3.2 Hz, H-9)
and a multiplet of an oxymethylene at δH 3.56 (2H, m, H-1”). Furthermore, the 1H–NMR spectrum
showed signals of a methyl at δH 0.85 (3H, t, J = 6.8 Hz, H-8′), and seven methylene groups at δH
2.55–1.23 (14H, brs, H-1′ to H-7′), characteristic of an n-octyl moiety [4,13–15,20,21]. The location of
both the double bonds and the oxymethylene was confirmed from the HMBC spectrum (Figure S6)
where correlations of H-4/C-3, C-6, and C-13, H-5/C-3, C-6, C-7, and C-1”, and H-8/C-6, C-7, and
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C-10, were observed. These correlations confirmed that compound 11a is an ∆4,5 and ∆8,9 unsaturated
tetracyclic endiandric acid derived alcohol with an oxymethylene at C-6. Based on these information
compound 11a was concluded to be the product of reduction of the carboxylic group of beilschmiedic
acid E (11) to which a trivial name beilschmiedol A (Figure 1) was given.
Molecules 2020, 25, x 3 of 16 
Molecules 2020, 25, x; doi: www.mdpi.com/journal/molecules 
H-8ʹ), and seven methylene groups at δH 2.55–1.23 (14H, brs, H-1′ to H-7′), characteristic of an n-
octyl moiety [4,13–15,20,21]. The location of both the double bonds and the oxymethylene was 
confirmed from the HMBC spectrum (Figure S6) where correlations of H-4/C-3, C-6, and C-13, H-
5/C-3, C-6, C-7, and C-1′′, and H-8/C-6, C-7, and C-10, were observed. These correlations confirmed 
that compound 11a is an ∆4,5 and ∆8,9 unsaturated tetracyclic endiandric acid derived alcohol with 
an oxymethylene at C-6. Based on these information compound 11a was concluded to be the 
product of reduction of the carboxylic group of beilschmiedic acid E (11) to which a trivial name 
beilschmiedol A (Figure 1) was given. 
 
Scheme 1. Scheme of semi-synthetic derivatives of beilschmiedic acid E (11) (11a–11d). 
Table 1. 13C NMR and 1H NMR data of compounds 1, 2 (150 and 600 MHz), and 11a (100 and 400 
MHz) in CDCl3. 
Position  
1 2 11a 
δC δH (m, J In 
Hz) 
δC δH (J In Hz) δC δH (J In Hz) 
1 41.6 2.19, m 41.4 2.18, m 41.6 2.21, m 
2a 35.1 1.22, m 37.4 1.40, m 35.1 1.23, m 
2b  1.50, m  2.54, m  1.52, m 
3 37.4 1.40, m 36.8 1.62, m 37.4 1.43, m 
4a 134.2 6.10 (d, 8.0) 32.1 1.82, m 133.9 6.10 (dt, 10.0, 2.4) 
4b    2.18, m   
5 127.9 5.53 (d, 8.0) 126.0 5.74, brs 127.9 5.50 (dt, 10.0, 2.8) 
6 47.2 2.12, m 141.6 - 47.2 2.14, m 
7 35.4 2.42, m 34.4 2.67, brs 35.4 2.18, m 
8 131.3 5.47 (d, 8.0) 126.1 5.53, m 131.4 5.39 (brdd, 10.0, 0.8) 
9 128.9 5.48 (brdt, 
9.6, 1.8) 
128.2 5.53, m 128.8 5.56 (dt, 10.0, 3.2) 
10 33.3 2.53, m 33.7 2.54, s 33.3 2.55, m 
11 46.3 1.40, m 45.9 1.40, m 46.2 1.43, m 
12 33.1 2.42, m 34.9 2.82, m 32.9 2.43, m 
13 42.7 1.50, m 42.9 2.54, m 42.6 1.53, m 
1′a 37.4 1.40, m 37.4 1.40, m 37.4 1.43, m 
1′b  2.54, m  2.54, m  2.55, m 
2′ 27.2 1.22, m 27.2 1.22, m 27.2 1.23, m 
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Table 1. 13C–NMR and 1H–NMR data of compounds 1, 2 (150 and 600 MHz), and 11a (100 and
400 MHz) in CDCl3.
Position
1 2 11a
δC δH (m, J In Hz) δC δH (J In Hz) δC δH (J In Hz)
1 41.6 2.19, m 41.4 2.18, m 41.6 2.21, m
2a 35.1 1.22, m 37.4 1.40, m 35.1 1.23, m
b 1.50, m 2.54, m 1.52, m
3 37.4 1.40, m 36.8 1.62, m 37.4 1.43, m
4a 134.2 6.10 (d, 8.0) 32.1 1.82, m 133.9 6.10 (dt, 10.0, 2.4)
4b 2.18, m
5 127.9 5.53 (d, 8.0) 126.0 5.74, brs 127.9 5.50 (dt, 10.0, 2.8)
6 47.2 2.12, m 141.6 - 47.2 2.14, m
7 35.4 2.42, m 34.4 2.67, brs 35.4 2.18, m
8 131.3 5.47 (d, 8.0) 126.1 5.53, m 131.4 5.39 (brdd, 10.0,0.8)
9 128.9 5.48 (brdt, 9.6, 1.8) 128.2 5.53, m 128.8 5.56 (dt, 10.0, 3.2)
10 33.3 2.53, m 33.7 2.54, s 33.3 2.55, m
11 46.3 1.40, m 45.9 1.40, m 46.2 1.43, m
12 33.1 2.42, m 34.9 2.82, m 32.9 2.43, m
13 42.7 1.50, m 42.9 2.54, m 42.6 1.53, m
1′a 37.4 1.40, m 37.4 1.40, m 37.4 1.43, m
1′b 2.54, m 2.54, m 2.55, m
2′ 27.2 1.22, m 27.2 1.22, m 27.2 1.23, m
3′–6′ 29.5–29.9 1.16, m 29.5–29.9 a 1.16, m 29.5–29.9 1.23, m
7′ 32.1 1.19, m 32.1 1.16, m 22.8 1.25, m
8′ 2 .8 1.22, m 22.8 1.22, m 14.3 0.85 (t, 6.8)
9′ 14.3 0.81 (t, 6.9) 14.3 0.81 (t, 6.9)
1” 67.6 3.63, m 65.5 4.12, m 67.3 3.56, m
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Figure 1. Isolated compounds from the roots of Beilschmiedia louisii and the stem bark of B. obscura
(1–15) and semi-synthetic derivatives (11a–11d).
The oxidation of the alcoholic group of 11a using the Dess Martin periodinane as an oxidizing
reagent [22] yielded the aldehyde 11b (Scheme 1) as an off-yellow oil. In fact, the 1H and 13C–NMR
data of 11b (Table 2; Figures S8 and S9) were nearly similar to those of compound 11a. However,
some noticeable discrepancies were observed on the 1H–NMR spectrum where the oxymethylene
protons at δH 3.56 (2H, m, H-1”) were replaced by an aldehyde proton at δH 9.46 (1H, s, H-1”).
In addition, the proton spectrum of 11b exhibited the resonances of only three olefinic proton at
δH 5.40 (1H, m, H-8), 5.49 (1H, m, H-9), and 6.81 (1H, t, J = 5.2 Hz, H-5) suggesting that a rearrangement
had occurred. This was confirmed by the characteristic signal of the aldehyde carbonyl in the 13C–NMR
spectrum at δC 193.9 (C-1”), replacing the oxymethylene carbon at δC 67.3 (C-1”) in compound 11a.
In addition, this spectrum also exhibited resonances of olefinic carbons at δC 154.0 (C-6), 145.9 (C-5),
127.8 (C-8), and 126.1 (C-9). Based on these data, compound 11b was concluded to be a new aldehyde
derivative to which the trivial name beilschmiedal (Figure 1) was given.
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Table 2. 13C–NMR (100 MHz) data of compounds, 11b, 11c, and 11d in CDCl3 and pyridine-d5.
Position 11b a 11c b 11d a
1 41.4 42.2 41.4
2 37.2 36.8 35.0
3 41.9 41.5 37.4
4 32.1 32.8 133.9
5 145.9 139.5 127.1
6 154.0 139.7 46.1
7 33.3 33.1 35.2
8 127.8 127.8 129.0
9 126.1 127.6 130.5
10 34.6 35.0 33.2
11 45.9 45.9 43.6
12 33.4 33.8 33.2
13 36.8 36.8 42.4
1′ 37.4 37.4 37.4
2′ 27.2 27.4 27.0
3′ 29.8 29.9 29.7
4′ 29.5 29.6 29.3
5′ 29.8 29.9 29.7
6′ 31.3 32.1 31.9
7′ 22.8 22.9 22.7
8′ 14.3 14.3 14.3
1′′ 193.9 145.5 68.9
1′′′ 180.4 166.3
2′′′ 125.3
3′′′ 106.8
4′′′ 152.9
5′′′ 142.2
6′′′ 152.9
7′′′ 106.8
4′′′/6′′′-OMe 56.2
5′′′-OMe 60.9
Where (a) stands for CDCl3 and (b) for pyridine-d5.
The derivatization of compound 11b with thiosemicarbazide reagent [23] led to compound 11c
(Scheme 1) as a white amorphous powder. The molecular formula of 11c, C23H35N3S, with eight
degrees of unsaturation, was deduced from its NMR data and the high-resolution electrospray
ionization (HRESIMS; Figure S10), which showed the protonated molecular ion peak [M + H]+ at m/z
386.2658 (calcd for C23H34N3S, 386.2624). The 1H and 13C–NMR data of the two compounds 11c and
11b (Table 2; Figures S11 and S12) were close to each other except some remarkable discrepancies.
The main discrepancy observed in the 13C–NMR spectrum of 11c was the signal of a conjugated
imine at δC 145.5 (C-1”) in replacement of the aldehyde carbonyl group at δC 193.9 (C-1”) in 11b.
In addition, the 13C–NMR spectrum showed the signal of the thiocarbonyl carbon resonance at
180.4 (C-2”), the shielded ∆5,6 carbon resonances at δC 139.7 (C-6) and 139.5 (C-5). Discrepancies were
also observed on the 1H–NMR spectrum, where the aldehyde proton at δH 9.46 (1H, s, H-1”) in 11b was
replaced by four other proton signals at δH 12.43 (1H, s, NH-1), 9.63 (1H, s, NH2-1), 8.39 (1H, s, H-1”),
and 8.01 (1H, s, NH2-2). Based on the above evidences, compound 11c was determined as a new
beilschmiedic acid (D) derivative to which the trivial name beilschmiecarbazone (Figure 1) was given.
The nucleophilic addition of compound 11a with 3,4,5-trimethoxybenzoic acid [24] led to
compound 11d (Scheme 1) as a white amorphous powder. The 1H and 13C–NMR data of 11d
(Table 2) displayed some similarities with those of 11a except that there are additional signals due to
the addition of the trimethoxygalloyloxy moiety. In fact, the 13C–NMR spectrum of 11d (Figure S18)
showed, in addition to signals of 11a, one signal of a carboxyl group at δC 166.3 (C-1′′′), signals of a
3,4,5-trisubstituted benzene ring at δC 125.3 (C-2′′′), 106.8 (C-3′′′/7′′′), 152.9 (C-4′′′/6′′′), 142.2 (C-5′′′),
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and signals of three oxymethyl groups at δC 60.9 (5′′′-OMe) and 56.2 (4′′′/6′′′-OMe). This was further
confirmed by the 1H–NMR spectrum (Figure S17), which exhibited a singlet of two protons at δH
7.23 (2H, s, H-3′′′/7′′′) and two singlets of three methoxy groups at δH 3.83 (6H, s, 3′′′/5′′′-OMe) and
3.85 (3H, s, 4′′′-OMe). Based on the above data, compound 11d was confirmed as a new derivative of
beilschmiedic acid E (11) trivially named beilschmiegallate (Figure 1).
The mixture of compounds 1 and 2 was obtained as a yellowish oil with the same Rf on the
thin layer chromatography (TLC) in different systems. Its HRESIMS spectra (Figure S20) showed the
potassium adducts peak [M + K]+ at m/z 367.2303 (calcd for C23H37KO, 367.2398). The combination
of this data with those of the 1H and 13C–NMR spectra clearly indicated that the yellowish sample
was the mixture of two isomers. In fact, the 13C–NMR spectrum (Figure S22) supported by DEPT
and HSQC (Figure S24) data displayed 34 carbon signals including one quaternary olefinic carbon
at δC 141.6 (C-6, 2), twenty-two methine carbons (including seven olefinic methine carbons at δC
126.0 (C-5, 2), 126.1 (C-8, 2), 127.9 (C-5, 1), 128.2 (C-9, 2), 128.9 (C-9, 1), 131.3 (C-8, 1), and 134.2
(C-4, 1)), twenty-one methylene carbons (including two oxymethylenes at δC 65.5 (C-1”, 2) and 67.6
(C-1”, 1)), and methyl carbon signal at δC 14.3. The 13C–NMR spectrum of 1 and 2 (Table 1) also
exhibited characteristic signals for molecules containing an aliphatic long chain moiety at δC 29.9–29.5.
In addition, the 13C–NMR spectrum of the mixture exhibited characteristic carbon signals for two
tetracyclic endiandric acid skeletons where, one contains an ∆4,5 and ∆8,9 and the other an ∆5,6 and ∆8,9
carbon–carbon double bond equivalents [4,13–15,20,21]. These observations were confirmed from the
fact that carbon resonances of one of the constituents (1) were nearly similar to those of compound 11a.
The main dissimilarity between these compounds was at the level of their masses, which differ by 14
amu. The 1H–NMR spectrum (Table 1; Figure S21) of the mixture showed signals of seven olefinic
proton resonances between δH 5.42–6.10, confirming the presence of the two tetracyclic endiandric
acid skeletons, one with a ∆4,5 and ∆8,9 and the other with a ∆5,6 and ∆8,9 [4]. Key HMBC correlations
(Figure 2 and Figure S25) observed between the oxymethylene proton at δH 4.12 (2) and the carbons
at δC 34.4 (C-7, 2), 126.0 (C-5, 2), and 141.6 (C-6, 2) and also between the olefinic proton at δH 5.74
(H-5, 2) and the carbons at δC 34.4 (C-7, 2), 36.8 (C-3, 2), and 65.5 (C-1”, 2) were useful to locate the
methylene group at C-4 in compound 2. Based on these data, it was concluded that compounds 1 and
2 were two new ∆4,5 and ∆8,9 and ∆5,6 and ∆8,9 alcohols with endiandric acid skeletons, to which the
trivial names beilschmiedol B and C (Figure 1) were given, respectively.
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Diels-Alder reaction [4,20,21,25]. As a result of the whole reaction sequence, an open-chain 
compound is converted into a tetracyclic compound. The starting product contains a conjugated 
tetraene system, as well as a conjugated diene system. Thus, it already displays the π electron 
systems required for the three pericyclic reactions; they are the two electrocyclizations and the 
Diels-Alder reaction [4,20,21,25]. 
Figure 2. Key HMBC (→) cor el s for compounds 1 a, 1, 2, and 3.
The stereochemistry of all the endiandric acid derivatives was deduced from their biosynthesis.
They are products of electrocyclic ring closures of naturally occurring polyketides, resulting from both
the shikimate and acetate pathways. Their biosynthesis from the polyketide contains two consecutive
non-enzymatic electrocyclic reactions, followed by an intramolecular Diels-Alder reaction [4,20,21,25].
As a result of the whole eaction sequen e, an o en-chain compound is converted into a tracyclic
compound. The starting product contains a conjugated tetraene syst m, as well as a conjugated diene
system. Thus, it already displays the π electron systems required for the three pericyclic reactions;
they are the two electrocyclizations and the Diels-Alder reaction [4,20,21,25].
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Compound 3 was isolated as colorless oil. The molecular formula C16H24 accounting for five double
bond equivalents was assigned based on NMR data (Figures S26–S30) and HRESIMS, which showed
the sodium adduct peak [M + Na]+ at m/z 239.1540 (calcd 239.1770 for C16H24Na). The 13C–NMR
spectrum of compound 3 (Table 3) exhibited signals of 16 carbons, which were sorted by DEPT and
HSQC into one quaternary carbon at δC 142.9 (C-1′), seven olefinic methine groups at δC 125.6 (C-4′),
128.4 (C-2′/6′), 128.2 (C-3′/5′), 130.1 (C-5), and 130.2 (C-6), seven methylene groups between δC 22.6
and 36.0, and one methyl group at δC 14.1 (C-10). Its 1H–NMR spectrum displayed signals for a triplet
of one methyl at δH 0.80 (3H, t, J = 6.4 Hz, H-10), methylene groups between δH 1.19 and 2.70, two
olefinic protons at δH 5.28 (2H, t, H-5,6), and a monosubstituted aromatic ring between δH 7.10 and
7.20. From this information, it can be deduced that compound 3 is an n-alkene with a phenyl moiety.
The C-5/C-6 position of the double bond was deduced from the HRESIMS, which showed an intense
peak at m/z 173.0524 corresponding to the loss of a C3H7- fragment. The geometry of the double bond
was assigned as cis based on the chemical shift of C-4 (27.3) and C-7 (25.7). It is known that the signals
of the carbons next to a trans double bond appear at δ ≈ 32, while those of a cis double bond appear at
δ ≈ 27 [26,27]. The identification of the carbon atoms next to the double was made through the HMBC
correlations of H-5/C-4, H-6/C-7, H2-4/C-5, and H2-7/C-6. However, most of these data were close to
those of the previously described synthetic compound, benzene-5E-decen-1-yl with clear difference at
the level of carbons adjacent to the double bond, which confers the Z configuration to compound 3 [28].
Based on the above data, compound 3 was assigned as a new stereoisomer, (5Z) 1-phenyldec-5-ene, to
which the trivial name obscurene (Figure 1) was given.
Table 3. 13C– and 1H–NMR (400 MHz) data of compound 3 in CDCl3.
Position
3
δC δH (J In Hz)
1 36.0 2.52, m
2 31.6 1.53, m
3 29.7 1.23, brs
4 27.3 1.98, m
5 130.1 5.28, m
6 130.2 5.28, m
7 25.7 2.69, m
8 29.4 1.18, brs
9 22.6 1.21, brs
10 14.1 0.80 (t, 6.4)
1′ 142.9
2′ 128.4 7.09–7.20, m
3′ 128.2 7.09–7.20, m
4′ 125.6 7.09–7.20, m
5′ 128.2 7.09–7.20, m
6′ 128.4 7.09–7.20, m
Pentacos-1-ene (4) was obtained as colorless oil. Its molecular formula was assigned as C25H50
(one degree of unsaturation) according to HRESIMS, which showed a deprotonated molecular ion
peak [M − H]+ at m/z 349.1892. The broad band decoupled 13C–NMR spectrum (Table 4; Figure S31)
of 4 displayed characteristic signals for an aliphatic compound (including a methyl group at δC14.1
(C-25) and a long chain carbon signals between 29.4 and 29.7) with terminal double bond (including
a methylene at δC 139.3 (C-1) and an olefinic methine at δC 114.1 (C-2)). The 1HNMR spectrum
(Figure S32) showed signals of a terminal aliphatic alkene at δH 4.96 (1H, brd, J = 10.2 Hz, H-1a), 5.02
(1H, brd, J = 17.4 Hz, H-1b), and 5.84 (1H, m, H-2). This spectrum also exhibited signals of a long chain
carbon between 1.29 and 2.07 ppm and of a methyl group at δH 0.91 (3H, t, J = 7.2 Hz, H-25). Therefore,
pentacos-1-ene (4) previously identified in the essential oil from the flowers of Chrysanthemum coronarium
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and from the cork of the wine through gas chromatography-mass spectrometry (GCMS) [9,10] is
isolated here for the first time and its NMR data reported.
Table 4. 13C– and 1H–NMR (400 MHz) data of compound 4 in CDCl3.
Position
4
δC δH (J In Hz)
1a 114.1 4.94 (brd, 10.2)
1b 5.02 (brd, 17.4)
2 139.3 5.84, m
3 31.9 2.07, m
4–23 29.4–29.7 1.29, brs
24 22.7 1.39, m
25 14.1 0.91 (t, 7.2)
2.2. In Vitro Antiplasmodial and Antitrypanosomal Activities
Extracts and isolated compounds from both plants were screened for their in vitro antiparasitic
activity against the Plasmodium falciparum strain Pf3D7 and Trypanosoma brucei brucei (Table 5).
Samples that reduced parasite viability to < 20% were considered for dose-response assay to determine
the IC50 value. The MeOH/CH2Cl2 (1:1) extract from the roots of B. louisii exhibited very good
antitrypanosomal activity against Tb brucei with an IC50 value of 4.6 µg/mL, while the extracts of stem
bark of B. obscura and leaves of B. louisii exhibited moderate activities against the same strain with IC50
values of 21.6 and 13.8 µg/mL, respectively (Table 5).
Table 5. Antimalarial, antitrypanosmal activities, and cytotoxicity of extracts and isolated compounds.
% Cell Viability ± sd IC50 a
Sample Tb Brucei Pf3D7 Cytotoxicity Tb Brucei Pf3D7
B. louisii
Roots
TE 1.50 ± 0.09 99.1 ± 15.3 100.0 ± 14.1 4.62 -
NF 19.5 ± 4.2 34.8 ± 8.9 100.0 ± 1.3 20.94 -
AF 79.7 ± 0.6 100.0 ± 7.8 100.0 ± 19.2 - -
Leaves
TE 9.7 ± 0.7 72.5 ± 3.4 100.0 ± 2.3 13.82 -
NF 97.5 ± 3.5 74.6 ± 1.2 100.0 ± 4.4 - -
AF 35.8 ± 10.4 100.0 ± 6.2 100.0 ± 4.3 - -
B. obscura Stem bark
TE 4.4 ± 0.7 70.4 ± 2.1 100.0 ± 5.5 21.59 -
NF nd nd nd nd nd
AF 6.9 ± 1.7 69.5 ± 9.6 100.0 ± 1.7 16.88 -
1 + 2 0.45 ± 0.40 97.1 ± 3.6 100.0 ± 14.0 4.91 -
3 99.1 ± 1.2 85.8 ± 6.0 50.3 ± 8.9 - -
4 nd nd nd nd nd
5 7.13 ± 3.90 78.3 ± 4.7 76.6 ± 4.1 90.10 -
6 + 7 0.1 ± 0.8 96.5 ± 0.3 100.0 ± 6.6 ≤15.2 * -
8 + 9 78.5 ± 1.2 95.0 ± 1.1 100.0 ± 0.2 - -
10 35.6 ± 6.9 100.0 ± 8.1 99.8 ± 4.6 - -
11 99.1 ± 7.4 100.0 ± 8.1 100.0 ± 5.8 - -
12 79.5 ± 8.4 100.0 ± 1.9 100.0 ± 10.8 - -
13 0.03 ± 0.06 82.2 ± 5.7 100.0 ± 11.3 9.51 -
14 nd nd nd nd nd
15 95.8 ± 2.5 100.0 ± 17.9 90.5 ± 5.0 - -
11a 8.6 ± 0.8 79.7 ± 3.7 52.6 ± 1.8 64.80 -
11b 10.8 ± 1.2 21.8 ± 8.0 79.6 ± 17.1 26.53 31.42
11c 96.3 ± 6.2 92.6 ± 2.9 100.0 ± 2.8 - -
11d 100.0 ± 9.3 96.6 ± 0.8 100.0 ± 3.4 - -
Pentamidine 0.04
Chloroquine 0.034
Emetine 0.014
TE = Total extract; NF = Neutral fraction; AF = Alkaloid fraction; a IC50 in µg/mL for extracts, fractions and in µM
for isolated compounds; * IC50 maximum calculated with the constituent having the lowest molecular mass in the
mixture; nd: Not determined.
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The non-alkaloid fraction of the roots extract of B. louissi was moderately active, while the alkaloid
rich fraction was non-active. Regarding the leaves, only the total extract showed a moderate activity.
In both cases, the synergetic effect of the alkaloid and the non-alkaloid fractions could be evident.
Each extract was partitioned into alkaloid and neutral fractions. Alkaloid fractions and neutral
fractions were also evaluated for their antitrypanosomal and antimalarial activities. The alkaloid
fractions of the stem bark of B. obscura exhibited moderate antitrypanosomal activity with an IC50
value of 16.9 µg/mL. Amongst the neutral fractions, only that of the roots of B. louisii showed moderate
antitrypanosomal activity against Tb brucei in vitro with an IC50 value of 20.9 µg/mL.
The isolated compounds and synthetic derivatives were also tested for their antitrypanosomal
and antimalarial activities. Compounds 1–2 are position isomers (double bond) while 6–7 are chain
(length) isomers. Both mixtures were showing a single spot on TLC card, indicating their same
retardation factor. All the attempts to separate such isomers were unsuccessful independently to the
different separation techniques used. Among the tested compounds, the mixtures 1–2, 6–7, and 13
showed good antitrypanosomal activity with IC50 values of 4.91, ≤15.2, and 9.50 µM, respectively.
From the synthetic derivatives, compound 11b showed the best antitrypanosomal activity with an IC50
value of 8.3 µg/mL while the starting compound, beilschmiedic acid E was inactive against the same
strain. Its alcohol derivative (11a) exhibited moderate activity. From the results obtained, it appears
that the most active compounds are alcohols. The presence of this functional group may be important
for the activity. In addition, the activity of the mixtures 1–2 and 6–7 may be due to synergetic action of
their constituents. The antitrypanosomal potential of endiandric acid derivatives is reported here for
the first time. The active mixture 6–7 consists of two lactones, class of secondary metabolites known
whose antitrypanosomal potential was reported previously by Oleivera et al. (2019) [29].
Cytotoxicity assays were also carried out on the extract and compounds, and they were found to
be non-toxic. With regard to the antiplasmodial activity, only the synthetic derivative 11b exhibited a
moderate activity with an IC50 value of 31.42 µM.
To the best of our knowledge, B. louisii has not yet been subject of chemical and biological
investigation. The Lauraceae family remains the only source of bioactive endiandric acid derivatives.
Beilschmiedia and Endiandra genus (Lauraceae) are well known for a long time as a rich source of
biologically active secondary metabolites. They are still the only source of this class of secondary
metabolites [30]. The genus Beilschmiedia is a pantropical genus of about 287 species, only 24 species
have been studied phytochemically so far. Endiandric acid derivatives are major constituents of
these genera, and are important chemotaxonomic markers used to identify Beilschmiedia plant species
from a phytochemical point of view [3]. In previous studies, endiandric acid has been isolated
from B. obstusifolia, B. introrsa, B. jonesii, B. toorom, B. oligandra, B. manii, B. fulva, B. anarcardioides,
B. erythrophoia, B. tsangii, B. cryptocaryoides, and B. ferruginea. This is the first time that this class of
secondary metabolites is reported from B. louisii and B. obscura. This study is important as far as
the chemotaxonomy of Beilschmiedia species is concerned and, and highlights the antitrypanosomal
potential of endiandric acid and lactone derivatives.
3. Materials and Methods
3.1. Chemicals and Reagents
The organic solvents (from Fisher, Waltham, MA, US) used for the extraction of plant material
and for column chromatography (CC) were of technical and laboratory grade, while those use
in reactions were of analytical grade. For column chromatography, the main solvents used
were n-hexane, dichloromethane, ethyl acetate, and methanol, used as pure or binary mixtures
at different concentrations for purification of compounds. Silica gel 230–400 and 70–230 mesh
(Merck) were used for column chromatography with different mixtures of n-hexane-ethyl acetate, and
dichloromethane-methanol solvent systems as eluents. Iodine or vanillin reagent (1.0 g of vanillin in
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70 mL ethanol 96% + 10 mL concentrated sulfuric acid) was used to reveal the spots of compounds on
TLC cards.
3.2. Instruments and Apparatus
NMR spectra were recorded on Bruker DRX-600 MHz spectrometer (Bruker, Rheinstetten,
Germany) operating at 75, 100, 150, 300, 400, and 600 MHz, where chemical shifts (δ) are given in
ppm with reference to the TMS signal. HR-ESI-MS were recorded on a Bruker Compact Q-TOF
mass spectrometer (Bremen, Germany) equipped with DionexUltiMate 3000 UHPLC and electrospray
ionization (ESI). For the direct infusion MS, the spectrometer operated in positive and negative modes
(mass range: 100–1500, with a scan rate of 1.00 Hz) with automatic gain control to provide high-accuracy
mass measurements within 1 ppm deviation using sodium formate as calibrant. The spray voltage
was 4.5 kV with a capillary temperature of 200 ◦C. The flow rate of sample was 180 µL/h and nitrogen
were used as sheath gas (4 L/min). Pre-coated aluminum silica gel 60 F254 sheets were used for TLC.
Spots were visualized with UV light (254 and 365 nm).
3.3. Plant Material
The roots and leaves of B. louisii were collected in April 2014 at Batshenga, Centre Region of
Cameroon. The stem bark of B. obscura was collected in April 2016 at Mont Kalla, Centre Region of
Cameroon. The plants were identified by Mr Nana Victor, plant taxonomist at the National Herbarium
of Cameroon where voucher specimen (B. obscura, N◦ 3360/SRFK and B. louissii, N◦ 6933/SRF/Cam)
were deposited.
3.4. Extraction and Isolation
The air-dried roots (2.5 kg) and leaves (1.0 kg) of B. louisii, and stem bark (2.0 kg) of B. obscura, were
separately ground and extracted with a mixture of CH2Cl2-MeOH (1:1) for 48 h at room temperature
each (about 25 ◦C). The different filtrates were freed from solvent under vacuum to give the crude
extracts (roots (350.0 g, 14.0%) and leaves (130.0 g, 13.0%) of B. louisii, and stem bark (300.0 g, 7.0%) of
B. obscura). Each extract was partitioned into neutral (roots (300.0 g) and leaves (80.0 g) of B. louisii,
and stem bark (200.0 g) of B. obscura) and alkaloid (roots (8.6 g) and leaves (2.0 g) of B. louisii, and
stem bark (2.0 g) of B. obscura) rich fractions, as described by Pudjastuti [31]. Each crude extract was
separately dissolved in cold distilled water and defatted with n-hexane. The aqueous layers were then
acidified with hydrochloric acid (5% HCl) to pH 3 to obtain acidic solutions that were then extracted
with dichloromethane to lead to neutral fractions. The remaining aqueous acidic phases were then
made alkaline by adding ammonium hydroxide (25% NH4OH) solution to pH 11 and extracted with
dichloromethane to afford the alkaloid fractions.
The neutral fraction (180 g) of stem bark of B. obscura was subjected to a flash chromatography
over silica gel 60 (230–400 mesh, Merck, 300 g) and eluted with mixtures of n-hexane/EtOAc
and EtOAc/MeOH of increasing polarities. Eighty fractions of 500 mL each were collected and
combined according to their TLC profiles into five main sub-fractions (A–E). Sub-fractions A (24.3 g),
D (26.8 g), and E (13.3 g) were complex mixtures that were not further studied. Sub-fraction
C (52.9 g) was subjected to repeated column chromatography over silica gel (70–230 mesh, Merck,
150 g) and eluted with a mixture of n-hexane/EtOAc of increasing polarities (19:1→2:3) to yield the
binary mixture of beilschmiedol B and beilschmiedol C (1 and 2, 8 mg) and obscurene A (3, 10 mg),
pentacosan-1-ene (4, 35 mg), and 15-phenylpentadecanoic acid (5, 15 mg). Sub-fraction B (62.7 g)
was equally subjected to column chromatography over silica gel (70–230 mesh, Merck, 230 g)
and eluted with the mixture of n-hexane/EtOAc of increasing polarities (9:1→7:3) to give the
binary mixture of (3S,4R,5S)-4-hydroxy-5-methyl-3-(11′-phenyl-1′-n-undecyl)-butanolide (6) and
(3S,4R,5S)-4-hydroxy-5-methyl-3-(13′–phenyl-1′-n-tridecyl)- butanolide (7) (6 and 7, 30 mg).
The neutral fraction (280 g) of roots B. louisii was also subjected to flash chromatography as
the previous one to yield sub-fractions (F-L). Fraction G (40 g) was subjected to repeated column
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chromatography over silica gel (70–230 mesh, Merck, 300 g) and eluted with n-hexane and resulted in
the isolation of the binary mixture of beilschmiedic acid A and beilschmiedic acid C (8 and 9, 80 mg).
Fraction F (100 g) was also subjected to column chromatography over silica gel (70–230 mesh, Merck,
200 g) and eluted with a mixture of n-hexane/EtOAc (9:1→7:3) to yield compounds beilschmiedic
acid D (10, 11 mg) and beilschmiedic acid E (11, 10 g). Fraction H (17 g) was treated as fraction G to
yield methylenedioxyendiandric acid A (12, 60 mg) and β-sitosterol (13, 50 mg). Fraction K (10 g) was
purified on a silica gel (70–230 mesh, Merck, 50 g) column with the isocratic mixture of n-hexane/EtOAc
(1:1) as eluent to yield compounds epicatechin (14, 10 mg) and β-sitosterol-3-O-β-D-glucopyranoside
(15, 75 mg). The neutral fraction of the leaves afforded β-sitosterol (13, 25 mg), hydrocarbons, and fatty
acid compounds, which structures were not determined. Repeated column chromatography of alkaloid
fractions of the roots of B. louisii and the stem bark of B. obscura over alumina gel afforded five
compounds that were not characterized due to the non-solubility in NMR solvents.
3.5. Semi-Synthetic Reactions
3.5.1. Synthesis of Compound 11a (Beilschmiedol A)
The solution of Beilschmiedic acid E (11) 3 mmol in THF (10 mL) was cooled to −5 ◦C using
ice/NaCl bath and lithium aluminum hydride (LiAlH4), 3.5 mmol, was carefully added to the above
solution in portions, while maintaining the temperature lower than 0 ◦C. The mixture was then allowed
to rise to room temperature gradually and stirred at room temperature for 48 h. The mixture was
quenched using petroleum ether (50 mL) and a solution of 10% of NaOH (30 mL) was added dropwise.
The mixture was then extracted with petroleum ether (3 × 50 mL). The organic phases were combined,
washed with the saturated brine and dried over MgSO4. The solvent was removed from the resulting
solution under vacuum to afford compound 11a as an off-yellow oil (980 mg, 98%).
3.5.2. Synthesis of Compound 11b (Beilschmiedal)
In a 100 mL round bottom flask equipped with a magnetic stirrer, a solution of Dess-Martin
periodinane (DMP) reagent (3.3 mmol), dissolved in methylene dichloride (DCM, 10 mL) was placed.
In a beaker, compound 11a (3 mmol) was dissolved in 10 mL of DCM, and then slowly added to the
DMP solution while stirring. The mixture was stirred at room temperature for 24 h. The reaction
mixture was diluted with diethyl ether (50 mL), then quenched by pouring it into a 250 mL beaker
containing saturated aqueous sodium bicarbonate solution (15 mL) with sodium thiosulfate (2.5 g).
The mixture was stirred for 15 min and transferred into a separation funnel where the layers were
allowed to separate. The aqueous layer was discarded, and the organic layer washed with water
and saturated brine, successively, and dried over MgSO4. The organic layer was then freed from
solvent under vacuum and purified on column chromatography (silica gel; hex-AE (9:1)) to yield
compound 11b as an off-yellow oil (350 mg, 70%).
3.5.3. Synthesis of Compound 11c (Beilschmiecarbazone)
In a round bottom flask, compound 11b (20 mmol) was dissolved in 100 mL of ethanol. A solution
of thiosemicarbazide reagent (20 mmol dissolved in 20 mL of 1 N hydrochloric acid) was prepared
in a beaker and added into a round bottom flask containing the compound 11b. The mixture was
stirred at room temperature (at about 25 ◦C) to afford compound 11c (245 mg, 70%) as a precipitate.
The precipitate was filtered, dried, and then recrystallized in ethanol (96 ◦C).
3.5.4. Synthesis of Compound 11d (Beilschmiegallate)
3,4,5-Trimethoxybenzoic acid (1.0 equiv.) and 4-(N,N-dimethylamino) pyridine (DMAP, 0.1 equiv.)
were dissolved in CH2Cl2 (10 mL) placed in a round bottom flash and compound 11a (3.0 equiv.) was
added. After 30 min of stirring at room temperature (at about 25 ◦C), the reaction mixture was cooled
to 0 ◦C and N,N-dicyclohexylcarbodiimide (DCC; 1.0 equiv.) was added in one portion. The mixture
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was allowed to stir at room temperature overnight, and urea was filtered off using a kieselguhr plug.
The organic solvent was removed under reduced pressure and the organic residue was purified on
column chromatography over silica gel using CH2Cl2 as a solvent to yield compound 11d (400 mg,
80%).
3.6. Spectroscopic Data
Beilschmiedol A (11a) yellowish oil. HRESIMS [M + K]+ at m/z 353.2241 (calcd for C22H34KO,
353.2247), 13C–NMR and 1HNMR (CDCl3), see Table 1.
Beilschmiedal (11b) yellowish oil, 13C–NMR (CDCl3), see Table 2.
Beilschmiecarbazone (11c) powder, HRESIMS [M + H]+ at m/z 386.2624 (calcd for C23H34N3S,
386.2630), 13C–NMR (CDCl3), see Table 2.
Beilschmiegallate (11d) colorless oil, HRESIMS [M + K]+ at m/z 547.2820 (calcd for C32H44KO5,
547.2826), 13C–NMR (CDCl3), see Table 2.
Beilschmiedol B and beilschmiedol C (1 and 2) colorless oily, HRESIMS [M + K]+ at m/z 367.2398,
13C–NMR and 1HNMR (CDCl3), see Table 1.
Obscurene (3) colorless oil, HRESIMS [M + Na]+ at m/z 239.1770, 13C–NMR and 1HNMR (CDCl3),
see Table 3.
Pentacosan-1-ene (4) colorless oil, HRESIMS [M −H]+ at m/z 349.1892, 13C–NMR and 1HNMR
(CDCl3), see Table 4.
3.7. Biological Activities
3.7.1. In Vitro Antiplasmodial Assay
The antiplasmodial assay was carried out using the pLDH assay as described by Makler. [32]
with little modification against the chloroquine-sensitive 3D7 strain of P. falciparum (Pf 3D7). Malaria
parasites (Pf 3D7) were maintained in RPMI 1640 medium containing 2 mM L-glutamine and 25 mM
Hepes (Lonza) further supplemented with 5% Albumax II, 20 mM glucose, 0.65 mM hypoxanthine,
60 µg/mL gentamycin, and 2–4% hematocrit human red blood cells. The parasites were cultured
at 37 ◦C under an atmosphere of 5% CO2, 5% O2, and 90% N2 in a sealed T75 culture flask. Single
concentration screening was conducted using solutions of 50 µg/mL of the extract and 20 µg/mL of pure
or combined compounds. The combinations were obtained by mixing solutions of single corresponding
compounds volume by volume. Samples were further added to parasite cultures in 96-well clear plates
and incubated in a 37 ◦C CO2 incubator. After 48 h, 20 µL of culture was removed from each well
and combined with 125 µL of a mixture of Malstat and NBT/PES solutions in a fresh 96-well plate.
These solutions measured the activity of the parasite lactate dehydrogenase (pLDH) enzyme in the
cultures. A purple product formed when pLDH was active, was then quantified by Spectramax M3
microplate reader (Abs620) from Molecular Devices LLC. The Abs620 reading in each well reflected the
pLDH activity and hence the number of parasites present. For each sample concentration, % parasite
viability–the pLDH activity in sample treated wells relative to untreated controls was calculated.
Samples were tested in triplicate and standard deviations (SD) derived. Samples that reduced parasite
viability to ≤20% from the single concentration assay were used in a dose response assay to determine
the 50% inhibitory concentration (IC50) values. For that, samples were serially diluted and tested as
described by Makler et al. [32]. Samples were tested in triplicate and for each, the percentage viability
was plotted against Log (concentration) and the IC50 value obtained from the resulting dose-response
curve by non-linear regression. Chloroquine was used as a drug standard and yielded IC50 values in
the range 0.008 µg/mL.
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3.7.2. In Vitro Antitrypanosomal Assay
To assess the trypanocidal activity, samples were added to cultures of Tb brucei in 96-well plates at
a fixed concentration of 20 µg/mL for single and combined compounds and 50 µg/mL for the extracts.
After 48 h of incubation, parasites surviving drug treatment were measured by adding a resazurin.
Resazurin is reduced to resorufin (a fluorophore (Exc560/Em590)) in viable cells and was quantified
using a Spectramax M3 microplate reader. Results were expressed as % parasite viability–the resorufin
fluorescence in sample treated wells relative to untreated controls. Samples were tested in triplicate and
standard deviations (SD) derived. Samples that reduced parasite viability to < 20% were considered
for dose-response assay to determine the IC50 value. In brief, samples were serially diluted and tested
in duplicate. Percentage viability was plotted against Log (concentration) and the IC50 obtained from
the resulting dose-response curve by non-linear regression. Pentamidine was used as a drug standard
and yielded IC50 values in the range 0.01 µg/mL [33].
3.7.3. Cytotoxicity Assay
Human cervix adenocarcinoma cells (HeLa cells) were used to check the toxicity of the crude extract
and compounds and their combinations as described by Keusch et al. (1972) [34]. Stocks solutions
were prepared in DMSO at a concentration of 50 µg/mL for the extracts and 20 µM for compounds,
and combinations. To assess the overt cytotoxicity, samples were placed in 96-well plates containing
cells for 48 h. The numbers of cells surviving drug treatment were determined using the resazurin
based reagent and reading resorufin fluorescence in a Spectramax M3 microplate reader. Results were
expressed as % viability–the resorufin fluorescence in compound-treated wells relative to untreated
controls. Compounds were tested in duplicate and standard deviations (SD) derived. Emetine (which
induces cell apoptosis) was used as the positive control.
4. Conclusions
Phytochemical investigation of the MeOH/CH2Cl2 (1:1) extract of the roots and leaves of
Beilschmiedia louisii and B. obscura, which showed potent antitrypanosomal activity during preliminary
screening on T. brucei led to the isolation of a mixture of two new endiandric acid derivatives 1
and 2, and one new phenylalkene (3) along with twelve known compounds (4–15). In addition,
four new derivatives (11a, 11b, 11c, and 11d) were synthesized from compound 11. Furthermore,
the isolates were evaluated for their antitrypanosomal and antimalarial activities against Tb brucei and
the P. falciparum chloroquine-resistant strain Pf3D7 in vitro, respectively. From the tested compounds,
the mixture of the new compounds exhibited potent antitrypanosomal activity in vitro with IC50
value of 1.61 µg/mL. The extracts and compounds from both plants were not toxic against human
cervix adenocarcinoma cells (HeLa cells) and the extract of the roots of B. louisii exhibited the good
antitrypanosomal activity with an IC50 value of 4.62 µg/mL.
Supplementary Materials: The following are available online, Figure S1: 13C–NMR (CDCl3, 100 MHz) spectrum
of compound 11a; Figure S2: 1H–NMR (CDCl3, 400 MHz) spectrum of compound 11a; Figure S3: 13C DEPT-135
(CDCl3, 100 MHz) spectrum of compound 11a; Figure S4: COSY (CDCl3, 400 MHz) spectrum of compound 11a;
Figure S5: HSQC (CDCl3, 400 MHz) spectrum of compound 11a; Figure S6: HMBC (CDCl3, 400 MHz) spectrum of
compound 11a; Figure S7: NOESY (CDCl3, 400 MHz) spectrum of compound 11a; Figure S8: 13C–NMR (CDCl3,
100 MHz) spectrum of compound 11b; Figure S9: 1H–NMR (CDCl3, 400 MHz) spectrum of compound 11b;
Figure S10: ESI mass spectrum of compound 11c; Figure S11: 1H–NMR (Pyridine-d5, 400 MHz) spectrum of
compound 11c; Figure S12: 13C–NMR (Pyridine-d5, 100 MHz) spectrum of compound 11c; Figure S13: COSY
(Pyridine-d5, 400 MHz) spectrum of compound 11c; Figure S14: HSQC (Pyridine-d5, 400 MHz) spectrum of
compound 11c; Figure S15: HMBC (Pyridine-d5, 400 MHz) spectrum of compound 11c; Figure S16: NOESY
(Pyridine-d5, 400 MHz) spectrum of compound 11c; Figure S17: 1H–NMR (CDCl3, 400 MHz) spectrum of
compound 11d; Figure S18: 13C–NMR (CDCl3, 100 MHz) spectrum of compound 11d; Figure S19: HSQC (CDCl3,
400 MHz) spectrum of compound 11d; Figure S20: ESI MASS spectrum of the mixture of compound 1 and 2;
Figure S21: 1H–NMR (CDCl3, 600 MHz) spectrum of the mixture of compound 1 and 2; Figure S22: 13C–NMR
(CDCl3, 150 MHz) spectrum of the mixture of compound 1 and 2; Figure S23: COSY (CDCl3, 600 MHz) spectrum
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of the mixture of compound 1 and 2; Figure S24: HSQC (CDCl3, 600 MHz) spectrum of the mixture of compound 1
and 2; Figure S25: HMBC (CDCl3, 600 MHz) spectrum of the mixture of compound 1 and 2; Figure S26: 1H–NMR
(CDCl3, 400 MHz) spectrum of compound 3; Figure S27: 13C–NMR (CDCl3, 100 MHz) spectrum of compound 3;
Figure S28: COSY (CDCl3, 400 MHz) spectrum of compound 3; Figure S29: HSQC (CDCl3, 400 MHz) spectrum of
compound 3; Figure S30: HMBC (CDCl3, 400 MHz) spectrum of compound 3; Figure S31: 13C–NMR (CDCl3,
150 MHz) spectrum of compound 4; Figure S32: 1H–NMR (CDCl3, 600 MHz) spectrum of compound 4; Figure S33:
1H–NMR (CDCl3, 300 MHz) spectrum of compound 11; Figure S34: 13C–NMR (CDCl3, 75 MHz) spectrum of
compound 11.
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